System and method for early identification of safety concerns of new drugs
A drug registry database is administered by storing healthcare claims for a plurality of patients and providing a user interface that displays new drug/comparator drug pairings in which a new drug includes a threshold number of healthcare claims and a comparator drug with substantially similar medical indications as the new drug. Based on receiving a new drug/comparator drug pairing selection, an analysis engine identifies from healthcare claims a statistically matched first of patients having used the new drug and second group of patients having used the comparator drug; identifies a comparative occurrence of existing medical conditions or new medical conditions in the statistically matched groups; and calculates a probability value indicating a relative likelihood that a patient taking the new drug will have a medical condition from the new or existing medical conditions in comparison to a likelihood that a patient taking the comparator drug will have the medical condition.
1. A computer-implemented system for administering a drug registry database, comprising:
an electronic database configured to store a plurality of healthcare claims for a plurality of patients;
an electronic user interface configured to
display a plurality of new drug/comparator drug pairings, wherein the plurality of new drug/comparator drug pairings include a new drug for which a threshold number of healthcare claims have been received and a comparator drug that has substantially similar medical indications as the new drug; and
receive a selection of a new drug/comparator drug pairing; and
an analysis engine configured to
search the healthcare claims stored in the database to identify a statistically matched first and second group of patients, wherein the first group includes patients with claim data indicating use of the new drug and the second group includes patients with claim data indicating use of the comparator drug and are statistically matched with demographic characteristics of the patients in the first group;
identify a comparative occurrence of existing medical conditions or new medical conditions in the statistically matched first and second groups of patients; and
calculate a probability value indicating a relative likelihood that a patient taking the new drug will have a medical condition from the new or existing medical conditions in comparison to a likelihood that a patient taking the comparator drug will have the medical condition;
wherein the electronic user interface displays the medical condition and the probability value in accordance with one or more report parameters entered by the user.
2. The system according to claim 1 , wherein the display generated by the electronic user interface includes at least one of demographic characteristics, prevalence of diagnosis, prevalence of procedures, prevalence of drug class and healthcare utilization.
3. The system according to claim 1 , wherein the patients in the second group are statistically matched with health insurance experiences of the patients in the first group.
4. The system according to claim 1 , wherein the patients in the second group are statistically matched to the patients in the first group in at least one category including age, sex, geographic region, diagnoses, drugs dispensed, procedures performed, and generalists and specialists seen.
5. A computer-implemented method for administering a drug registry database, comprising:
storing a plurality of healthcare claims for a plurality of patients on a computing device;
displaying on a user interface a plurality of new drug/comparator drug pairings, wherein the plurality of new drug/comparator drug pairings include a new drug for which a threshold number of healthcare claims have been received and a comparator drug that has substantially similar medical indications as the new drug;
receiving a selection of a new drug/comparator drug pairing;
searching by an analysis engine the healthcare claims stored in the database to identify a statistically matched first and second group of patients, wherein the first group includes patients with claim data indicating use of the new drug and the second group includes patients with claim data indicating use of the comparator drug and are statistically matched with demographic characteristics of the patients in the first group;
identifying a comparative occurrence of existing medical conditions or new medical conditions in the statistically matched first and second groups of patients;
calculating a probability value indicating a relative likelihood that a patient taking the new drug will have a medical condition from the new or existing medical conditions in comparison to a likelihood that a patient taking the comparator drug will have the medical condition; and
displaying the medical condition and the probability value in accordance with one or more report parameters entered by the user.
6. The method according to claim 5 , wherein the display generated by the user interface includes demographic characteristics, prevalence of diagnosis, prevalence of procedures, prevalence of drug class, or healthcare utilization.
7. The method of claim 5 , wherein the patients in the second group are statistically matched with health insurance experiences of the patients in the first group.
8. The method according to claim 5 , wherein the patients in the second group are statistically matched to the patients in the first group in at least one category including age, sex, geographic region, diagnoses, drugs dispensed, procedures performed, and generalists and specialists seen.